Rockwell Medical (RMTI) Cash from Investing Activities Growth (1y) (2011 - 2026)
Rockwell Medical (RMTI) Cash from Investing Activities Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.92 Bn | 42.96 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.53 Bn | 2.15 Bn | -308.05% |
| 3 | Zoetis | 31.74 Bn | 30.06 Bn | 1.05 Bn | -41.51% |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.87 Bn | 5.10 Bn | -139.86% |
| 5 | United Therapeutics | 22.22 Bn | 19.56 Bn | 683.80 Mn | 129.18% |
| 6 | Viatris | 18.71 Bn | 17.83 Bn | 1.46 Bn | 1.71% |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | -366.90% |
| 8 | Elanco Animal Health | 11.80 Bn | 11.27 Bn | 798.00 Mn | -96.43% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Rockwell Medical | 29.81 Mn | 5.01 Mn | 3.24 Mn | -372.82% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -372.82% |
| Mar 31, 2026 | -12,100.00% |
| Dec 31, 2025 | -1,144.28% |
| Sep 30, 2025 | 29.50% |
| Jun 30, 2025 | -106.00% |
| Mar 31, 2025 | 99.28% |
| Dec 31, 2024 | -116.53% |
| Sep 30, 2024 | 40.61% |
| Jun 30, 2024 | 2,782.81% |
| Mar 31, 2024 | -102.62% |
| Dec 31, 2023 | -37.60% |
| Sep 30, 2023 | 29.97% |
| Jun 30, 2023 | -25.49% |
| Mar 31, 2023 | -41.95% |
| Dec 31, 2022 | 495.93% |
| Sep 30, 2022 | -977.42% |
| Jun 30, 2022 | -103.10% |
| Mar 31, 2022 | 1,883.79% |
| Dec 31, 2021 | -15.23% |
| Sep 30, 2021 | -172.75% |